Jpmorgan Chase & CO Staar Surgical CO Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Staar Surgical CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 54,153 shares of STAA stock, worth $964,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,153
Previous 166,648
67.5%
Holding current value
$964,464
Previous $4.05 Million
76.43%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding STAA
# of Institutions
209Shares Held
52.1MCall Options Held
154KPut Options Held
260K-
Broadwood Capital Inc New York, NY12.5MShares$222 Million18.31% of portfolio
-
Black Rock Inc. New York, NY7.49MShares$133 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.42MShares$96.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3MShares$53.4 Million0.81% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.56MShares$45.6 Million3.74% of portfolio
About STAAR SURGICAL CO
- Ticker STAA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 48,038,300
- Market Cap $856M
- Description
- STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...